Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2020-03-11EMA Authorised: Clopidogrel BGR (previously Zylagren) (clopidogrel (as hydrogen sulfate)) — Biogaran
European Medicines Agency authorised Clopidogrel BGR (clopidogrel as hydrogen sulfate) by Biogaran for peripheral vascular diseases, stroke,…
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients [Phase 4]
Phase 4 clinical trial update examining the efficacy and safety of adjunctive cilostazol in patients with acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention [Phase 4]
A Phase 4 clinical trial comparing vascular closure devices to transradial approach in primary PCI for myocardial infarction and related vas…
-
CLINICAL_TRIALS research · 2020-02-11Clinical Trial Update: Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus [Phase 4]
Phase 4 clinical trial updating optimized antithrombotic therapy for patients with acute myocardial infarction and left ventricular mural th…
-
FDA approval · 2020-02-05FDA Approved: TICAGRELOR — Supplemental Application (Hisun Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Ticagrelor from Hisun Pharmaceuticals USA, Inc., confirming approval of the generic ticagrel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) [Phase 2]
Phase 2 trial update for The TRIDENT Study evaluating transendocardial stem cell injection delivery effects on neomyogenesis in chronic isch…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus [Phase 4]
Phase 4 trial evaluating vorapaxar as add-on antiplatelet therapy in patients with and without diabetes mellitus in the setting of myocardia…
-
CLINICAL_TRIALS research · 2020-01-18Clinical Trial Update: Automated Hovering to Improve Medication Adherence Among Myocardial Infarction Patients (Heartstrong) [NA]
A completed clinical trial evaluating automated hovering to improve medication adherence in myocardial infarction patients; results posted i…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3) [Phase 2, Phase 3]
Phase 2/3 clinical trial for IL-1 blockade in acute myocardial infarction has completed with results posted.
-
FDA approval · 2019-12-13FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for Clopidogrel Bisulfate from Radha Pharmaceuticals, Inc., confirming approval of their generic pro…
-
FDA approval · 2019-12-13FDA Approved: CAPTOPRIL — Original Application (Ajanta Pharma USA Inc.)
This document reports the FDA approval of CAPTOPRIL as a generic product (Original Application) by Ajanta Pharma USA Inc.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Mechanisms of Action of Acetaminophen [NA]
Clinical trial updating the mechanisms of action of acetaminophen, completed with results posted in December 2019. The study involved patien…
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: PPI's and SSRI's Therapy for the Management of NCCP [Phase 4]
Phase 4 trial update on PPI and SSRI therapy for managing non-cardiac chest pain; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study [Phase 3]
A Phase 3 multicenter trial evaluating microvascular integrity and left ventricular function recovery after clopidogrel or ticagrelor admini…
-
CLINICAL_TRIALS withdrawal · 2019-11-21Clinical Trial Update: Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction [Phase 2, Phase 3]
A clinical trial evaluating testosterone replacement to improve exercise capacity in hypogonadal men after acute myocardial infarction has b…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 [Phase 2]
Phase 2 trial updating clopidogrel escalation using a genetic strategy in myocardial infarction patients undergoing percutaneous coronary in…
-
EMA approval · 2019-11-13EMA Authorised: Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) (clopidogrel;acetylsalicylic acid) — Sanofi-Aventis Groupe
European Medicines Agency authorised a clopidogrel and acetylsalicylic acid combination product (Zentiva/DuoCover) for acute coronary syndro…
-
FDA approval · 2019-11-06FDA Approved: CLOPIDOGREL — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for clopidogrel under ANDA090844, finalizing an approval for its gen…
-
FDA approval · 2019-11-06FDA Approved: VALSARTAN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for valsartan from Ascend Laboratories, updating the regulatory status of this generic antihypertens…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Management of Anger in Patients With Acute Myocardial Infarction (MAPAMI) [NA]
A completed clinical trial evaluating management of anger in patients after acute myocardial infarction, with results posted in 2019.
-
FDA approval · 2019-11-04FDA Approved: PRASUGREL — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for prasugrel (generic) under ANDA205987, granting approval for the generic prasug…
-
FDA approval · 2019-10-30FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc. under ANDA 078085, finalizing changes to the generic produc…
-
FDA approval · 2019-10-24FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare Corporation's supplemental application for Metoprolol Tartrate under ANDA 078950. This approval updates a…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction [Phase 4]
A Phase 4 clinical trial evaluating extracorporeal life support in patients with cardiogenic shock complicating acute myocardial infarction …
-
CLINICAL_TRIALS research · 2019-10-01Clinical Trial Update: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study [Phase 4]
A Phase 4 trial update assessing affordability and real-world effectiveness of antiplatelet treatment after myocardial infarction.